mass tort intelligence
X ANTE IS THE SOURCE FOR DATA AND ANALYSIS ON MASS TORT LITIGATION ADVERTISING.
Named for the Latin phrase ex ante - "before the event" - we deliver predictive and actionable intelligence to guide decision-making before the litigation begins.
mass tort intelligence
X ANTE IS THE SOURCE FOR DATA AND ANALYSIS ON MASS TORT LITIGATION ADVERTISING.
Named for the Latin phrase ex ante - "before the event" - we deliver predictive and actionable intelligence to guide decision-making before the litigation begins.
IN THE PRESS
RECENT PRESENTATIONS
October 20, 2015 HB Litigation Drug & Device Defense, Philadelphia, PA. Understanding plaintiffs-side advertising to forecast litigation trends, mitigate risk and defend product reputation. Presenter: Rustin Silverstein, X Ante.
WHAT WE OFFER
X Ante monitors and reports on advertising soliciting plaintiffs for mass tort litigation from across the United States.
MASS TORT AD ARCHIVE IMAGES
IN PRACTICE
X Ante intelligence serves Fortune 500 companies and top law firms from the boardroom to the courtroom. Read about some of our recent engagements.
SURVEILLANCE
Leading pharmaceutical company engages X Ante to monitor portfolio of drugs for appearances in mass tort ads as early signal of litigation threat.
FINANCIAL PLANNING
Medical device manufacturer subject to sizable litigation monitors advertising to forecast litigation reserves for future litigation and settlement negotiations.
TRIAL ARGUMENTS
Defense counsel uses X Ante data to argue that mass tort advertising - not product defects - drove adverse event reporting and lawsuit filings.
RECENT TRENDS
X Ante Monthly is the premier publication covering trends in mass tort advertising.
Monitor pharmaceuticals, medical devices and other products featured in advertising.